The central bank is willing to wait for inflation to catch up to employment before hiking rates.» Read More
U.S. drugmaker AbbVie's revenue beat analysts' estimates for the fourth straight quarter as sales of arthritis drug Humira jumped nearly 11 percent.
Jan 30- U.S. drugmaker AbbVie Inc's revenue beat analysts' estimates for the fourth straight quarter as sales of arthritis drug Humira jumped nearly 11 percent. Excluding the charge and other special items, AbbVie earned 89 cents per share. Sales of Humira, which AbbVie inherited from Abbott Laboratories in 2013, rose to $3.36 billion in the fourth quarter ended...
NEW YORK, Jan 28- Top U.S. health insurers say their businesses offering medical coverage under so-called Obamacare are turning into profitable ventures and that they are now aiming to be on par with other sought-after government health programs. This puts the business closer to a profit margin that many insurers earn on the government's Medicare Advantage...
Sam's Club is already seeing an uptick in spending as its customers spend less on gas, CEO Rosalind Brewer tells CNBC.
Some of Wednesday's midday movers:
Aetna raised employees' wages to a base of $16 per hour because doing otherwise would have put workers in poverty, CEO Mark Bertolini tells CNBC.
Dr. Toby Cosgrove, Cleveland Clinic CEO, and Ezekiel Emanuel, University of Pennsylvania, discuss the "enormous" changes taking place in the health care industry.
Mark Bertolini, Aetna chairman & CEO, discusses how he came up with the plan to boost wages.
Mark Bertolini, Aetna chairman & CEO, discusses what prompted him to raise the minimum wage for his workers.
SAN FRANCISCO/ WASHINGTON Jan 15- U.S. healthcare executives say Obamacare is likely here to stay, despite repeated calls from Republican lawmakers for repeal of the 2010 law aimed at providing health coverage for millions of uninsured Americans. Top executives who gathered in San Francisco this week for the annual J.P. Morgan Healthcare conference, say that...
Investors are watching closely to see how insurers decide to cover these drugs, which cost tens of thousands of dollars per treatment, after AbbVie Inc started a competitor to Gilead Sciences' breakthrough hepatitis C treatment. Express Scripts, the largest pharmacy benefit manager in the United States, dropped Gilead Sciences hepatitis C drugs from its main...
Some of Tuesday's midday movers:
A new year means a new strategy for one trader hoping for better returns in the Halftime Portfolio challenge.
Investors can find value in blue-chip health-care stocks and old-world tech names, and should stick to U.S. equities, Chad Morganlander said.
Nicolas Karlson had a sweet insurance plan for years. Then Obamacare happened, and he had to scramble for new coverage.
NEW YORK, Dec 15- Healthcare companies including Aetna Inc, Mercer and Towers Watson& Co have invested hundreds of millions of dollars to build exchanges that allow company employees to buy their own insurance, betting that Corporate America wants to get out of managing workers' health benefits. By last year, blue chip names such as Sears Holding Corp and Walgreen...
NEW YORK, Dec 15- Healthcare companies including Aetna Inc, Mercer and Towers Watson Co have invested hundreds of millions of dollars to build exchanges that allow company employees to buy their own insurance, betting that Corporate America wants to get out of managing workers' health benefits. By last year, blue chip names like Sears Holding and Walgreen Co had...
Starting Saturday, millions of Americans will begin to either re-enroll, or sign-up for the first time, for insurance plans at HealthCare.gov. Here's what investors need to know.
Obamacare's second open-enrollment season begins Saturday, with new deadlines, new technology and new projections of how many people will sign up.